← Parenteral Drug Association
FDANonrulemakingFDA-2009-N-0435

Current Good Manufacturing Practice Requirements for Combination Products-CLOSED

RIN
—
Last modified
Jan 5, 2022
Comment window
closed 6017d ago
Parenteral Drug Association filings
1

Activity

Parenteral Drug Association filed 1 comment on this docket between Feb 4, 2010 and Feb 4, 2010. 0 other organizations filed here. The comment window closed 6017d ago.

What Parenteral Drug Association filed (1)

Feb 4, 2010· Parenteral Drug Association (PDA) - Comment· FDA-2009-N-0435-0017

On behalf of the Parenteral Drug Association (PDA), we are pleased to submit comments on the Current Good Manufacturing Practice Requirements for Combination Products, Docket No. (f/k/a FDA-2008-D-0409]; extension of comment period Docket FDA-2009-N-0435-004]. Please note that this is the second attempt from PDA in that the "browse" and "attached" button froze and failed before the actual documentation was submitted.

View on regulations.gov →

Abstract

September 23, 2009 (74 FR 48423) FR document published with an incorrect docket number. This FR document was published to correct the Docket ID (FDA-2008-D-0409) 78 FR 4307 Eff.date 7/22/2013, Rules and Regulations published which closed the docket

View on regulations.gov →

Co-filers (0)

See everyone who commented →
Current Good Manufacturing Practice Requirements for Combination Products-CLOSED (FDA) — Parenteral Drug Association | OpenPolis